跳至主要内容
临床试验/DRKS00026239
DRKS00026239招募中不适用

Evaluation of whole-body MRI in diagnostic accuracy of extrahepatic metastases in neuroendocrine tumors compared with the gold standard SSR-PET/CT - NET_MET

Klinikum der Universität München, Campus Großhadern0 个研究点目标入组 20 人开始时间: 2023年2月3日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • Clinically indicated MRI examination,
  • Existing clinical indication for liver MRI,
  • Patient's legal capacity, available written documentation of the informed consent interview and patient's consent to participate in the study,
  • Additional SSTR- PET-CT at the same time points (maximum 3 months time difference).

排除标准

  • Impaired renal function (GFR < 30 ml/min/1.73m²),
  • Known intolerance of gadolinium-containing contrast agent,
  • Clinically or hemodynamically unstable patients,
  • Other contraindications to MRI examination (claustrophobia, pacemakers or other implants not compatible with 3T MRI, metal shards, etc.),
  • Pregnant women and nursing mothers

研究者

发起方
Klinikum der Universität München, Campus Großhadern

相似试验